Tech Healthcare Sector

Alliance Growers

Market Cap: US$85.0

Engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia.

Chalice Brands

Market Cap: US$84.0

Engages in the retail, production, processing, wholesale, and distribution of cannabis products.

Cardax

Market Cap: US$82.0

A biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.

Accelera Innovations

Market Cap: US$81.0

A healthcare service company, focuses on the development of Internet-based software in the United States.

Bioasis Technologies

Market Cap: US$79.0

A development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.

Yield10 Bioscience

Market Cap: US$73.0

Operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

Sunnylife Global

Market Cap: US$63.0

Owns and operates hospitals in China.

IMRIS

Market Cap: US$62.0

Designs, manufactures, and sells image-guided therapy solutions worldwide.

Avisa Diagnostics

Market Cap: US$59.0

Operates a clinical-stage medical device company.

MJ Holdings

Market Cap: US$58.0

A cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Arno Therapeutics

Market Cap: US$49.0

A biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases.

Callitas Health

Market Cap: US$45.0

Provides over the counter consumer health and wellness products in the United States and Canada.

Antigenics

Market Cap: US$45.0

A clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.

Skylight Health Group

Market Cap: US$41.0

Operates as a healthcare services and technology company in the United States.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

MedLink International

Market Cap: US$40.0

Engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data.

Response Genetics

Market Cap: US$38.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

Canntab Therapeutics

Market Cap: US$38.0

A phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada.

Claritas Pharmaceuticals

Market Cap: US$37.0

A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

Goodbody Health

Market Cap: US$36.0

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Aspyra

Market Cap: US$34.0

Provides health care products and services for the laboratory and imaging marketplaces.

ARYx Therapeutics

Market Cap: US$33.0

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets.

Holdco Nuvo Group D.G

Market Cap: US$33.0

Engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally.

Deltagen

Market Cap: US$32.0

Provides drug discovery tools and services to the biopharmaceutical industry.

LifeHOUSE Holdings

Market Cap: US$30.0

Operates senior assisted and independent living, and skilled nursing facilities in the United States.

Monarch Staffing

Market Cap: US$30.0

Provides healthcare staffing services to healthcare providers, state institutions, and related organizations in California.

Targeted Medical Pharma

Market Cap: US$29.0

A specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

Medivolve

Market Cap: US$27.0

A principal investment firm.